Kári Stéfansson

ORCID: 0000-0003-1676-864X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genetic Associations and Epidemiology
  • Epigenetics and DNA Methylation
  • Genomic variations and chromosomal abnormalities
  • Genomics and Rare Diseases
  • Nutrition, Genetics, and Disease
  • RNA modifications and cancer
  • Genetics and Neurodevelopmental Disorders
  • Genetic Mapping and Diversity in Plants and Animals
  • Genetic and phenotypic traits in livestock
  • Bioinformatics and Genomic Networks
  • BRCA gene mutations in cancer
  • Birth, Development, and Health
  • Metabolomics and Mass Spectrometry Studies
  • Cancer Genomics and Diagnostics
  • Cancer-related molecular mechanisms research
  • Asthma and respiratory diseases
  • Osteoarthritis Treatment and Mechanisms
  • Congenital heart defects research
  • RNA Research and Splicing
  • Genetic Syndromes and Imprinting
  • Autism Spectrum Disorder Research
  • Genetic factors in colorectal cancer
  • Migraine and Headache Studies
  • Lipoproteins and Cardiovascular Health
  • Genetic diversity and population structure

University of Iceland
2016-2025

deCODE Genetics (Iceland)
2016-2025

National University Hospital of Iceland
2007-2024

Amgen (Germany)
2016-2024

University of Tartu
2023-2024

University of Exeter
2021-2024

Reykjavík University
2007-2023

RMIT University
2023

Karolinska Institutet
2016-2023

Oslo University Hospital
2023

10.1038/nature08186 article EN Nature 2009-07-01

The global endemic of cardiovascular diseases calls for improved risk assessment and treatment. Here, we describe an association between myocardial infarction (MI) a common sequence variant on chromosome 9p21. This study included total 4587 cases 12,767 controls. identified variant, adjacent to the tumor suppressor genes CDKN2A CDKN2B, was associated with disease high significance. Approximately 21% individuals in population are homozygous this their estimated suffering is 1.64 times as...

10.1126/science.1142842 article EN Science 2007-05-04

BackgroundDuring the current worldwide pandemic, coronavirus disease 2019 (Covid-19) was first diagnosed in Iceland at end of February. However, data are limited on how SARS-CoV-2, virus that causes Covid-19, enters and spreads a population.MethodsWe targeted testing to persons living who were high risk for infection (mainly those symptomatic, had recently traveled high-risk countries, or contact with infected persons). We also carried out population screening using two strategies: issuing...

10.1056/nejmoa2006100 article EN New England Journal of Medicine 2020-04-14

Little is known about the nature and durability of humoral immune response to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).We measured antibodies in serum samples from 30,576 persons Iceland, using six assays (including two pan-immunoglobulin [pan-Ig] assays), we determined that appropriate measure seropositivity was a positive result both pan-Ig assays. We tested 2102 collected 1237 up 4 months after diagnosis by quantitative polymerase-chain-reaction (qPCR)...

10.1056/nejmoa2026116 article EN New England Journal of Medicine 2020-09-01
Coming Soon ...